new targets in osteoporosis therapy - eft-aktuell.ch · 2013-09-11 · neue targets in der...

71

Upload: others

Post on 07-Mar-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 2: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 3: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M. Jehle

„Solche Daten zeigen, dassdie Interfaces, die der Knochenzu anderen Organsystemenaufweist, sei es dasImmunsystem, die Muskulaturoder der Stoffwechsel,bislang erheblich unterschätztwurden und dass hierhochinteressante Entwicklungenmöglich sind, die über denKnochen alleine hinausgehen.“

Page 4: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

Science 3 June 2005 Vol. 308. no. 5727, pp. 1456 - 1460

Page 5: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

Science 3 June 2005 Vol. 308. no. 5727, pp. 1456 - 1460

Page 6: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

Science 3 June 2005 Vol. 308. no. 5727, pp. 1456 - 1460

Page 7: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 8: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 9: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

Ca

mammopoesis

RANK Ligand

Page 10: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

menstruation menstruationovulation

E2 P

IL6 IL6 IL6 IL1

resorption of bone synthesis of bone

osteoclast osteoblaststeadystate

IL6IL6

Page 11: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

determination proliferation differentation polarisation resorption

PV1 M-CSF

ranklc-fosNFB

V2TRAF6CSr6

cathepsin kcarbone

anhydrase IIH+-ATPase

Page 12: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 13: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

The breast and the skeleton communicate during lactation to provide a steady supply of calcium for milk production.

Wysolmerski J J JCEM 2012;97:2947-2956

©2012 by Endocrine Society

Page 14: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

PTHrPIL6

Osteoklasten GM-CSF

Ca

NFkB

Wachstumsfaktoren

Page 15: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

FornarinaLancet, 360, 2061 Fornarina

Page 16: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 17: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 18: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 19: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 20: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 21: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 22: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 23: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

Bone and the epidermo-pilosebaceous unit of the skin share alifelong renewal activity where similar molecular players operate,and because mammary glands and hair follicles are both skin

appendages

Page 24: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

Das Progesteron bereitet den weiblichen Körper auf die

Fortpflanzung vor

Page 25: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 26: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 27: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

Antirheumatika

unter 30 J.12%

30-39 J.14%

40-54 J.24%

55-64 J.21%

65+ J.29%

Alterstruktur Männer (22 Mio. Verordnungen)

Alterstruktur Frauen(32 Mio. Verordnungen)

unter 30 J.9%

30-39 J.9%

40-54 J.19%

55-64 J.18%

65+ J.45%

Quelle: IMS Health, VIP

50%50%63%

37%bis 54 ab 54 bis 54

ab 54

Page 28: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 29: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 30: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 31: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

Factors mediating luteal ce ll apoptosis in humans. The Fas and Fas-ligand and Bcl-2 and Bax systems are involved in the intracellu lar signaling pathway for apoptosis, and apoptosis is induced by caspase-3 activation. Cytokines may also be involved inapoptosis. HCG works as a survival factor by regulating apoptosis-related factors, such as Fas, the Bcl-2 and Bax syst em and survivin

Page 32: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 33: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 34: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 35: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 36: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 37: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 38: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 39: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 40: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 41: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 42: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

9 MAY 2 0 1 3 | VO L 4 9 7 | N AT U R E | 2 1 1

Page 43: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 44: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

Adiponectin

Cell 130, 456

Osteoblast

Osteocalcin

Leptin

Adipozyt

Osteocalcin-ZellenInsulin

Adiponectin

Pankreas

Page 45: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 46: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 47: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 48: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

Osteocalcin, a bone-derived multifunctional hormone. Undercarboxylated osteocalcin stimulates insulin secretion and β-cell proliferation in the pancreas, energy expenditure by muscle, and insulin sensitivity in adipose tissue, muscle and liver. In addition, it promotes male fertility by stimulating testosterone synthesis in Leydig cells of the testis through the activation of its receptor, GPRC6A, in these cells.

Page 49: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 50: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 51: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 52: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 53: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 54: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 55: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 56: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 57: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 58: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 59: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

Der zum Diabetes neigende Stoffwechsel und die Überproduktion an Androgenen verringern die Energieverluste durch Wärme und sorgen für den Aufbau von Fettdepots. Insulin trägt zusammen mit dem Hormon Leptin, das Appetit und Fettmasse reguliert, zum Erhalt von Energiebalance und der Funktion der Eierstöcke be

Leider wendet sich dieser evolutionsbiologisch angelegte Vorteil in Zeiten hochkalorischer Nahrungszufuhr ins Gegenteil

Page 60: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

Our results show for the first time that female O/PCOS-prone rats gain a survival advantage over their lean-prone congenics when confronted with a challenge of time-limited feeding and an opportunity for food-related activity

The longer survival of female O/PCOS-prone rats compared with their lean-prone congenics relates to higher baseline energy reserves, greater

When leptin signaling is defective, as in the O/PCOS-prone rats, the energy homeostasis pathway involving feeding-related peptides, such as neuropeptide Y, is impaired. This impairment results in increased appetite, decreased energy expenditure, and greater fat accumulation—effects that are advantageous for survival in the AAC

Page 61: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 62: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 63: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 64: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

Leider wendet sich dieser evolutionsbiologisch angelegte Vorteil in Zeiten hochkalorischer Nahrungszufuhr ins Gegenteil

Page 65: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

MESENCHYMAL STEM CELLS

MYOBLAST CHONDROCYT OSTEOBLAST ADIPOCYTE

Page 66: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M

24 OCTOBER 2008 VOL 322 SCIENCE

Page 67: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 68: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 69: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 70: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M
Page 71: New Targets in Osteoporosis Therapy - eft-aktuell.ch · 2013-09-11 · Neue Targets in der Osteoporosetherapie 12 New Targets in Osteoporosis Therapy F. Jakob, L. Seefried, P. M